港股异动 | 中集安瑞科(3899.HK)涨近4% 或将受惠分拆业务上市
格隆汇12月17日丨中集安瑞科(3899.HK)涨近4%,报4.45港元,总市值89.5亿港元。中集安瑞科及中集集团昨日公告,中集及中集安瑞科正考虑以中集安瑞环科技股份有限公司(前称南通中集罐式储运设备制造有限公司,"中集安瑞环科")独立于A股上市的方式将中集安瑞环科分拆及独立上市可行性。随着于2020年11月27日安瑞科公告的附属公司股权激励计划之完成,中集安瑞环科现时为安瑞科持股90%的附属公司,连同其附属公司主要从事制造及销售标准罐式集装箱、特种罐式集装箱及各式多式联运散装货物之设备;及制造及销售环保设备。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.